261 related articles for article (PubMed ID: 33188907)
41. Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines.
Wang K; Duan X; Gao F; Wang W; Liu L; Wang X
PLoS One; 2018; 13(9):e0203824. PubMed ID: 30216380
[TBL] [Abstract][Full Text] [Related]
42. SC(3): Triple spectral clustering-based consensus clustering framework for class discovery from cancer gene expression profiles.
Zhiwen Y; Le L; Jane Y; Hau-San W; Guoqiang H
IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(6):1751-65. PubMed ID: 22868680
[TBL] [Abstract][Full Text] [Related]
43. Model-based clustering with gene ranking using penalized mixtures of heavy-tailed distributions.
Cozzini A; Jasra A; Montana G
J Bioinform Comput Biol; 2013 Jun; 11(3):1341007. PubMed ID: 23796184
[TBL] [Abstract][Full Text] [Related]
44. Integrated multi-omics analysis of ovarian cancer using variational autoencoders.
Hira MT; Razzaque MA; Angione C; Scrivens J; Sawan S; Sarker M
Sci Rep; 2021 Mar; 11(1):6265. PubMed ID: 33737557
[TBL] [Abstract][Full Text] [Related]
45. Comparison of cancer subtype identification methods combined with feature selection methods in omics data analysis.
Park J; Lee JW; Park M
BioData Min; 2023 Jul; 16(1):18. PubMed ID: 37420304
[TBL] [Abstract][Full Text] [Related]
46. Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization.
Chalise P; Ni Y; Fridley BL
Comput Biol Med; 2020 Mar; 118():103625. PubMed ID: 31999549
[TBL] [Abstract][Full Text] [Related]
47. A novel pathway-based distance score enhances assessment of disease heterogeneity in gene expression.
Yan X; Liang A; Gomez J; Cohn L; Zhao H; Chupp GL
BMC Bioinformatics; 2017 Jun; 18(1):309. PubMed ID: 28637421
[TBL] [Abstract][Full Text] [Related]
48. A hierarchical clustering and data fusion approach for disease subtype discovery.
Pfeifer B; Schimek MG
J Biomed Inform; 2021 Jan; 113():103636. PubMed ID: 33271342
[TBL] [Abstract][Full Text] [Related]
49. Multi-cancer samples clustering via graph regularized low-rank representation method under sparse and symmetric constraints.
Wang J; Lu CH; Liu JX; Dai LY; Kong XZ
BMC Bioinformatics; 2019 Dec; 20(Suppl 22):718. PubMed ID: 31888442
[TBL] [Abstract][Full Text] [Related]
50. Consensus clustering applied to multi-omics disease subtyping.
Brière G; Darbo É; Thébault P; Uricaru R
BMC Bioinformatics; 2021 Jul; 22(1):361. PubMed ID: 34229612
[TBL] [Abstract][Full Text] [Related]
51. A Bayesian semiparametric factor analysis model for subtype identification.
Sun J; Warren JL; Zhao H
Stat Appl Genet Mol Biol; 2017 Apr; 16(2):145-158. PubMed ID: 28343169
[TBL] [Abstract][Full Text] [Related]
52. An enhanced deterministic K-Means clustering algorithm for cancer subtype prediction from gene expression data.
Nidheesh N; Abdul Nazeer KA; Ameer PM
Comput Biol Med; 2017 Dec; 91():213-221. PubMed ID: 29100115
[TBL] [Abstract][Full Text] [Related]
53. Statistical power for cluster analysis.
Dalmaijer ES; Nord CL; Astle DE
BMC Bioinformatics; 2022 May; 23(1):205. PubMed ID: 35641905
[TBL] [Abstract][Full Text] [Related]
54. Deep structure integrative representation of multi-omics data for cancer subtyping.
Yang B; Yang Y; Su X
Bioinformatics; 2022 Jun; 38(13):3337-3342. PubMed ID: 35639657
[TBL] [Abstract][Full Text] [Related]
55. [Automatic clustering method of flow cytometry data based on
Meng X; Wang Y; Zhu L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2018 Oct; 35(5):697-704. PubMed ID: 30370707
[TBL] [Abstract][Full Text] [Related]
56. Performance comparison of dimensionality reduction methods on RNA-Seq data from the GTEx project.
Seok HS
Genes Genomics; 2020 Feb; 42(2):225-234. PubMed ID: 31833048
[TBL] [Abstract][Full Text] [Related]
57. intCC: An efficient weighted integrative consensus clustering of multimodal data.
Huang C; Kuan PF
Pac Symp Biocomput; 2024; 29():627-640. PubMed ID: 38160311
[TBL] [Abstract][Full Text] [Related]
58. Interactive gene identification for cancer subtyping based on multi-omics clustering.
Ye X; Shi T; Cui Y; Sakurai T
Methods; 2023 Mar; 211():61-67. PubMed ID: 36804215
[TBL] [Abstract][Full Text] [Related]
59. Bayesian semi-nonnegative matrix tri-factorization to identify pathways associated with cancer phenotypes.
Park S; Kar N; Cheong JH; Hwang TH
Pac Symp Biocomput; 2020; 25():427-438. PubMed ID: 31797616
[TBL] [Abstract][Full Text] [Related]
60. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
